# Parecoxib as an Adjuvant to Scalp Nerve Blocks for Relief of Post-craniotomy Pain

> **NCT04034836** · PHASE4 · UNKNOWN · sponsor: **Beijing Tiantan Hospital** · enrollment: 132 (estimated)

## Conditions studied

- Pain, Postoperative
- Neurosurgery

## Interventions

- **DRUG:** Scalp blocks with ropivacaine plus parecoxib
- **DRUG:** Scalp blocks with ropivacaine and intravenous parecoxib
- **DRUG:** Scalp blocks with ropivacaine and intravenous saline

## Key facts

- **NCT ID:** NCT04034836
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-12
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2020-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04034836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04034836, "Parecoxib as an Adjuvant to Scalp Nerve Blocks for Relief of Post-craniotomy Pain". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04034836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*